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Recent studies show that NSF, isolated over 15 years
ago as a protein required for membrane fusion in
vitro, can be reversibly inactivated by both S-nitrosy-
lation and tyrosine phosphorylation. Different cell
types use distinct post-translational modifications of
NSF for localized regulation of membrane fusion.
The idea that intracellular membrane fusion events all
use the same basic protein machinery is now gener-
ally accepted. The first direct evidence for this came
when N-ethylmaleimide-sensitive fusion protein (NSF),
a soluble protein required for membrane fusion in the
mammalian Golgi in vitro, was shown to be the
ortholog of Sec18, a budding yeast protein essential
for membrane fusion in vivo [1]. Recruitment of NSF to
membranes involves adaptor proteins known as
soluble NSF attachment proteins (SNAPs), which bind
to membrane-bound SNAP receptors (SNAREs) [2].
SNAREs were first isolated from brain membranes by
their ability to bind recombinant NSF and SNAPs, and
identified as VAMP/synaptobrevin, syntaxin and
SNAP-25 [3]. These are all proteolytic substrates of
botulinum neurotoxins, potent blockers of synaptic
vesicle fusion, indicating that they are part of a
universal docking/fusion machinery, conserved from
yeast to the mammalian brain [4]. Homology between
the synaptic SNAREs and yeast proteins involved in
various membrane trafficking steps, coupled with the
recognition that α-SNAP is the ortholog of yeast
Sec17, further reinforced this idea [5].
NSF is a homo-hexameric ATPase and each
subunit has three domains (Figure 1). The amino-ter-
minal domain is required for SNAP/SNARE binding;
the D1 domain provides ATPase activity; and the D2
domain induces oligomerisation [6]. Binding of NSF
to SNAPs does not occur in solution; rather, a con-
formational change induced by SNARE binding
enables NSF recruitment, whereupon SNAPs stimu-
late NSF’s normally low intrinsic ATPase activity [7].
The energy liberated is used to disassemble the
SNARE complex [3].
Although the precise point at which this ATP-
dependent function of NSF acts was initially
controversial, it rapidly became clear that NSF does
not directly drive membrane fusion, but instead acts
as a molecular chaperone to disaggregate SNARE
complexes and thereby maintain a pool of free
SNAREs for subsequent fusion events [8]. NSF can
thus be thought of as a housekeeping protein, the job
of which is continually to recycle dead-end SNARE
complexes throughout the cell. Two recent studies
[9,10], however, show that cellular NSF activity is not
uniform and is in fact regulated by post-translational
modifications to enable both temporal and spatial
control over membrane fusion.
The first of these studies [9] focused on the
exocytosis of so-called Weibel-Palade bodies from
endothelial cells. Secretion of these organelles
mediates vascular thrombosis and inflammation, and
the anti-inflammatory action of nitric oxide (NO) is
thought to be due, in part, to inactivation of the
exocytosis machinery by NO. Having first established
a functional requirement for NSF, α-SNAP and the
SNAREs VAMP3, syntaxin 4 and SNAP-23 in Weibel-
Palade body exocytosis, Matsushita et al. [9] went on
to show that treatment of NSF with NO donors
blocks its ability to disassemble this SNARE
complex. Furthermore, the inhibition of exocytosis by
NO donors in permeabilized endothelial cells was
rescued by introduction of recombinant NSF, but not
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Figure 1. Post-translational modifications of NSF.
(A) The domain structure of an individual NSF polypeptide
(native NSF is a homohexamer). The residues targeted by S-
nitrosylation and phosphorylation are indicated. (B) Crystal
structure of the amino-terminal domain of NSF, showing the
locations of the modified cysteine (red) and tyrosine (yellow)
residues. The NA subdomain is in green and the NB subdomain
in cyan. Residues identified as being essential for SNAP
binding are in magenta. The structure is based on that solved
by Yu et al. [20] and was generated using Chimera software.
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NO-treated NSF, demonstrating that NSF is a major
cellular target of NO. 
Importantly, S-nitrosylation of endogenous cellular
NSF was inhibited by NO synthase antagonists and
absent in cells from endothelial NO synthase knockout
mice, strongly arguing that this post-translational
modification is physiologically relevant. Mutagenesis
of the nine cysteines in NSF implicated amino-domain
residues 21 and 91 and D1-domain residue 264 as
likely sites of S-nitrosylation (Figure 1). Analysis of
these mutants in assays of SNARE complex
disassembly, however, while consistent with an
important role for Cys91 and Cys264 in this process,
failed to identify convincingly the functionally impor-
tant residue(s) targeted by NO.
Similarly, the mechanism by which NO prevents
NSF-mediated SNARE complex disassembly remains
unclear. NO had no effect on SNAP binding or on
NSF’s intrinsic ATPase activity, though the effect of
NO on the stimulation of NSF ATPase activity by
SNAP was not examined. This biochemically distinct
ATPase activation is essential for efficient SNARE
disassembly, and indeed mutants of α-SNAP [11] and
NSF [12] that are defective in this function fail to
disassemble SNARE complexes, despite having
normal levels of intrinsic ATPase activity. The position
of Cys21 and Cys91 in the amino-domain crystal
structure is compatible with a role in the SNAP-
induced stimulation of NSF ATPase activity (Figure 1),
while Cys264 is located in the heart of the D1 domain
Walker A box that is involved in ATP binding. So it
may be that NO blocks ATPase activation by SNAPs
[13] (Figure 2), although this speculation remains to
be tested.
The focus for the second study [10] was the regula-
tion of secretory vesicle size in cells of haemopoietic
lineage. The starting point was the observation that
expression of a secretory vesicle-localized protein
tyrosine phosphatase, PTP-MEG2, induced the
formation of enlarged secretory vesicles in RBL cells
and Jurkat T cells as a result of increased homotypic
fusion of immature vesicles [14]. A search for tyrosine-
phosphorylated substrates of PTP-MEG2 that might
underlie this effect identified NSF and revealed Tyr83
as the likely phosphorylation site [10].
Phosphorylation of NSF in vitro by the tyrosine
kinase Fes had two effects: increased intrinsic ATPase
acitivity and decreased affinity for α-SNAP. Replacing
Tyr83 with glutamate had the same effect, strength-
ening the in vitro phosphorylation data and also con-
firming the phosphomimetic nature of this Y83E
mutant. Tyr83 is located at the junction between
NSF’s two amino-terminal sub-domains, as is the
Cys91 nitrosylation site (Figure 1), and phosphoryla-
tion of this residue would likely disrupt the interface
between the sub-domains and hence affect SNAP
binding [10]. Treatment with the PTP inhibitor per-
vanadate transiently reverses the increased vesicular
size induced by PTP-MEG2, indicating that tyrosine
phosphorylation/dephosphorylation regulates a
dynamic cycle of homotypic vesicle fusion and fission.
The observation that reformation of large vesicles fol-
lowing washout of pervanadate was abolished by
NEM provided indirect evidence that tyrosine phos-
phorylation of NSF might inhibit homotypic fusion. 
The really key observation, however, was that
expression of the putative dephospho-mimetic
mutant Y83F induced the formation of large vesicles
in a strikingly similar manner to PTP-MEG2. Although
it would have been interesting to push this further by
testing if the Y83F-expressing cells were now resis-
tant to pervanadate, these results nevertheless
strongly suggest that homotypic fusion of secretory
vesicles is regulated by phosphorylation of NSF on
Tyr83. Presumably, inhibition of NSF by tyrosine
kinases causes an accumulation of dead-end cis-
SNARE complexes and thereby inhibits homotypic
fusion, while local dephosphorylation via vesicular
PTP-MEG2 antagonises this effect. The same phos-
phorylation event appears also to affect heterotypic
fusion in exocytosis, as expression of phospho-
mimetic NSF-Y83E in Jurkat cells partially inhibited
interleukin-2 secretion.
Taken together, these two new studies [9,10] firmly
establish post-translational modification of NSF as an
important mechanism enabling localized inhibition of
membrane fusion in endothelial and haemopoietic
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Figure 2. Effects of post-translational modifications on the
NSF cycle.
Model for the mechanism of action of NSF in SNARE complex
disassembly, indicating the stages affected by post-translational
modifications. SNAP association with the SNARE complex
enables NSF binding to SNAP–SNARE complexes (inhibited by
Tyr83 and Ser237 phosphorylation). Subsequently, stimulation
of NSF ATPase activity by SNAP occurs, which in turn leads to
the disassembly of the complex (either or both processes inhib-
ited by S-nitrosylation). This completes the cycle and releases
NSF, SNAPs and SNAREs for further rounds of fusion.
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cells. Interestingly, earlier work demonstrated
depolarisation-induced NSF phosphorylation in brain
synaptosomes [15], suggesting that such regulation of
NSF may also occur in neurons. In this case,
phosphorylation of Ser237 by protein kinase C
inhibited NSF binding to the SNAP–SNARE complex
[15] — the same biochemical effect as Tyr83 phos-
phorylation [10]. Even transient and/or highly localized
inhibition of presynaptic NSF activity might potentially
have profound effects on synaptic transmission and
plasticity, and intriguingly, both NO donors and Src
family tyrosine kinases have been shown to inhibit
neurotransmitter release [16,17]. 
In addition to its presynaptic function in SNARE
complex disassembly, NSF has an important
postsynaptic role in regulating the surface expression
of GluR2 glutamate receptors [18], and has also been
shown to interact with various other proteins,
including GABARAP, GATE-16, and β-arrestin [19].
The recent work has shown how the specific localisa-
tion of an appropriate enzyme involved in post-trans-
lational modification can allow local regulation of a
protein with a wide spectrum of cellular roles. It will be
interesting to see if other membrane traffic steps or
the SNARE-independent functions of NSF are also
locally regulated by nitrosylation, phosphorylation and
indeed other post-translational modifications of NSF.
References
1. Wilson, D.W., Wilcox, C.A., Flynn, G.C., Chen, E., Kuang, W.,
Henzel, W.J., Block, M.R., Ullrich, A., and Rothman, J.E. (1989). A
fusion protein required for vesicle-mediated transport in both mam-
malian cells and yeast. Nature 339, 355–359.
2. Wilson, D.W., Whiteheart, S.W., Wiedmann, M., Brunner, M., and
Rothman, J.E. (1992). A multisubunit particle implicated in mem-
brane fusion. J. Cell Biol. 117, 531–538.
3. Sollner, T., Whiteheart, S.W., Brunner, M., Erdjument-Bromage, H.,
Geromanos, S., Tempst, P., and Rothman, J.E. (1993). SNAP recep-
tors implicated in vesicle targeting and fusion. Nature 362, 318–324.
4. Ferro-Novick, S., and Jahn, R. (1994). Vesicle fusion from yeast to
man. Nature 370, 191–193.
5. Rothman, J.E. (1994). Mechanisms of intracellular protein transport.
Nature 372, 55–62.
6. Whiteheart, S.W., Schraw, T., and Matveeva, E.A. (2001). N-ethyl-
maleimide sensitive factor (NSF) structure and function. Int. Rev.
Cytol. 207, 71–118.
7. Morgan, A., Dimaline, R., and Burgoyne, R.D. (1994). The ATPase
activity of N-Ethylmaleimide-sensitive fusion protein (NSF) is regu-
lated by soluble NSF attachment proteins. J. Biol. Chem. 269,
29347–29350.
8. Morgan, A., and Burgoyne, R.D. (1995). Is NSF a fusion protein?
Trends Cell Biol. 5, 335–339.
9. Matsushita, K., Morrell, C.N., Cambien, B., Yang, S.X., Yamakuchi,
M., Bao, C., Hara, M.R., Quick, R.A., Cao, W., O’Rourke, B., et al.
(2003). Nitric oxide regulates exocytosis by S-nitrosylation of N-eth-
ylmaleimide-sensitive factor. Cell 115, 139–150.
10. Huynh, H., Bottini, N., Williams, S., Cherepanov, V., Musumeci, L.,
Saito, K., Bruckner, S., Vachon, E., Wang, X., Kruger, J., et al. (2004).
Control of vesicle fusion by a tyrosine phosphatase. Nat. Cell Biol.
6, 831–839.
11. Barnard, R.J.O., Morgan, A., and Burgoyne, R.D. (1997). Stimulation
of NSF ATPase activity by a-SNAP is required for SNARE complex
disassembly and exocytosis. J. Cell Biol. 139, 875–883.
12. Horsnell, W.G., Steel, G.J., and Morgan, A. (2002). Analysis of NSF
mutants reveals residues involved in SNAP binding and ATPase
stimulation. Biochemistry 41, 5230–5235.
13. Sollner, T.H., and Sequeira, S. (2003). S-nitrosylation of NSF con-
trols membrane trafficking. Cell 115, 127–129.
14. Wang, X., Huynh, H., Gjorloff-Wingren, A., Monosov, E., Stridsberg,
M., Fukuda, M., and Mustelin, T. (2002). Enlargement of secretory
vesicles by protein tyrosine phosphatase PTP-MEG2 in rat
basophilic leukemia mast cells and Jurkat T cells. J. Immunol. 168,
4612–4619.
15. Matveeva, E.A., Whiteheart, S.W., Vanaman, T.C., and Slevin, J.T.
(2001). Phosphorylation of the N-ethylmaleimide-sensitive factor is
associated with depolarization-dependent neurotransmitter release
from synaptosomes. J. Biol. Chem. 276, 12174–12181.
16. Stanton, P.K., Winterer, J., Bailey, C.P., Kyrozis, A., Raginov, I.,
Laube, G., Veh, R.W., Nguyen, C.Q., and Muller, W. (2003). Long-
term depression of presynaptic release from the readily releasable
vesicle pool induced by NMDA receptor-dependent retrograde
nitric oxide. J. Neurosci. 23, 5936–5944.
17. Ohnishi, H., Yamamori, S., Ono, K., Aoyagi, K., Kondo, S., and Taka-
hashi, M. (2001). A src family tyrosine kinase inhibits neurotrans-
mitter release from neuronal cells. Proc. Natl. Acad. Sci. USA 98,
10930–10935.
18. Haas, A. (1998). NSF-fusion and beyond. Trends Cell Biol. 8,
471–473.
19. Whiteheart, S.W., and Matveeva, E.A. (2004). Multiple binding pro-
teins suggest diverse functions for the N-ethylmaleimide sensitive
factor. J. Struct. Biol. 146, 32–43.
20. Yu, R.C., Jahn, R., and Brunger, A.T. (1999). NSF N-terminal domain
crystal structure: models of NSF function. Mol. Cell 4, 97–107.
